Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 362 (9400) , 1959-1966
- https://doi.org/10.1016/s0140-6736(03)15014-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutininJournal of Medical Virology, 2003
- Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human populationVaccine, 2002
- Characterization of a human H9N2 influenza virus isolated in Hong KongVaccine, 2001
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolatesProceedings of the National Academy of Sciences, 2000
- Human infection with influenza H9N2The Lancet, 1999
- Molecular characterization of H9N2 influenza viruses: Were they the donors of the “internal” genes of H5N1 viruses in Hong Kong?Proceedings of the National Academy of Sciences, 1999
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusThe Lancet, 1998
- Molecular analysis of an outbreak of influenza in the United KingdomEuropean Journal of Epidemiology, 1997
- Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactionsJournal of Biological Standardization, 1979